ID   DLD-1 SIRT1 KO
AC   CVCL_ZC12
SY   DLD1 SIRT1 KO; SIRT1 KO DLD1
DR   Kerafast; ENH130-FP
DR   Wikidata; Q98125876
RX   PubMed=28162896;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 14929; SIRT1.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 5
//
RX   PubMed=28162896; DOI=10.1016/j.cub.2016.12.047;
RA   Ren N.S.-X., Ji M., Tokar E.J., Busch E.L., Xu X.-J., Lewis D., Li X.-C.,
RA   Jin A.-W., Zhang Y.-P., Wu W.K.-K., Huang W.-C., Li L.-P., Fargo D.C.,
RA   Keku T.O., Sandler R.S., Li X.-L.;
RT   "Haploinsufficiency of SIRT1 enhances glutamine metabolism and
RT   promotes cancer development.";
RL   Curr. Biol. 27:483-494(2017).
//